Psychiatry News & Articles

201 Curcumin as an Add-On to Antidepressive Treatment: A Randomized, Double-Blind, Placebo-Controlled, Pilot Clinical Study Clinical Neuropharmacology, May 16, 2013    Clinical Article

202 Amphetamine, past and present - a pharmacological and clinical perspective Journal of Psychopharmacology, May 16, 2013    Review Article    Clinical Article

203 Effectiveness and Safety of Memantine Treatment for Alzheimers Disease Journal of Alzheimer’s Disease, May 16, 2013    Clinical Article

204 Designing a Trial to Evaluate Potential Treatments for Apathy in Dementia: The Apathy in Dementia Methylphenidate Trial (ADMET) The American Journal of Geriatric Psychiatry, May 16, 2013    Clinical Article

205 Life Events and Psychosis: A Review and Meta-analysis Schizophrenia Bulletin, May 16, 2013    Evidence Based Medicine    Review Article

206 Pharmacologic Treatment of Anxiety Disorders in Parkinson Disease The American Journal of Geriatric Psychiatry, May 16, 2013    Clinical Article

207 Response randomization of one- and two-person Rock-Paper-Scissors games in individuals with schizophrenia Psychiatry Research, May 16, 2013    Clinical Article

208 Brain structural, neurochemical and neuroinflammatory markers of psychosis onset and relapse: Is there evidence for a psychosis relapse signature? International Clinical Psychopharmacology, May 16, 2013    Review Article

209 Personalized Cognitive Training in Unipolar and Bipolar Disorder: A Study of Cognitive Functioning Frontiers in Psychiatry, May 16, 2013    Clinical Article

210 Hypertransaminasemia in severely malnourished adult anorexia nervosa patients: Risk factors and evolution under enteral nutrition Clinical Nutrition, May 16, 2013    Clinical Article

211 Serious psychological distress among non-Hispanic whites in the United States: the importance of nativity status and region of birth Social Psychiatry and Psychiatric Epidemiology, May 16, 2013    Clinical Article

212 Dimensional assessment of depressive severity in the elderly general population: Psychometric evaluation of the PHQ-9 using Rasch Analysis Journal of Affective Disorders, May 16, 2013    Clinical Article

213 Assessment of everyday functioning in schizophrenia: Implications for treatments aimed at negative symptoms Schizophrenia Research, May 16, 2013    Clinical Article

214 Standardization of the depression screener Patient Health Questionnaire (PHQ-9) in the general population General Hospital Psychiatry, May 16, 2013    Clinical Article

215 Perceived emotional support in remission: results from an 18-month follow-up of patients with early episode psychosis Social Psychiatry and Psychiatric Epidemiology, May 16, 2013    Clinical Article

216 Heterogeneous trajectories of depressive symptoms: Adolescent predictors and adult outcomes Journal of Affective Disorders, May 16, 2013    Clinical Article

217 Plasma total cholesterol in psychiatric patients after a suicide attempt and in follow-up Journal of Affective Disorders, May 16, 2013    Clinical Article

218 Enhanced Anger Reactivity and Reduced Distress Tolerance in Major Depressive Disorder Cognitive Therapy and Research, May 16, 2013    Clinical Article

219 A Descriptive and Comparative Study From China On Patients With Type-2 Diabetes With and Without Depressive Symptoms Journal of Community Health Nursing, May 16, 2013    Clinical Article

220 Longitudinal relationship between depressive symptoms and work outcomes in clinically treated patients with long-term sickness absence related to major depressive disorder Journal of Affective Disorders, May 16, 2013    Clinical Article

1 Nidotherapy for people with schizophrenia Cochrane Reviews, April 11, 2013    Evidence Based Medicine

2 Newly diagnosed depression is associated with increased beta-thromboglobulin levels and increased expression of platelet activation markers and platelet derived CD40-CD40L Journal of Psychiatric Research, April 12, 2013

3 Use of asenapine in clinical practice for the management of bipolar mania Journal of Psychopharmacology, March 29, 2013    Review Article

4 Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study Neuropsychiatric Disease and Treatment, April 18, 2013    Free full text

5 Buprenorphine augmentation in the treatment of refractory obsessive-compulsive disorder Therapeutic Advances in Psychopharmacology, March 1, 2013

6 Efficacy and mood conversion rate during long-term fluoxetine v. lithium monotherapy in rapid- and non-rapid-cycling bipolar II disorder The British Journal of Psychiatry, April 3, 2013

7 The association between low vitamin D and depressive disorders Molecular Psychiatry, April 10, 2013    Free full text

8 A randomised, controlled trial of a dietary intervention for adults with major depression (the SMILES trial): study protocol BMC Psychiatry, April 19, 2013    Free full text

9 An open trial of pregabalin as an acute and maintenance adjunctive treatment for outpatients with treatment resistant bipolar disorder Journal of Affective Disorders, March 22, 2013

10 Add-on fluvoxamine treatment for schizophrenia: an updated meta-analysis of randomized controlled trials European Archives of Psychiatry and Clinical Neuroscience, April 22, 2013    Evidence Based Medicine

11 Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: A 12-month, double-blind, noninferiority study Schizophrenia Research, April 16, 2013

12 Rapid Effects of Deep Brain Stimulation for Treatment-Resistant Major Depression Biological Psychiatry, April 8, 2013

13 Reboxetine Treatment for Autistic Spectrum Disorder of Pediatric Patients With Depressive and Inattentive/Hyperactive Symptoms: An Open-Label Trial Clinical Neuropharmacology, April 5, 2013

14 Lower CSF Interleukin-6 predicts future depression in a population-based sample of older women followed for 17 years Brain, Behavior, and Immunity, April 19, 2013
Exclusive Author Commentary

15 Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression Human Psychopharmacology: Clinical and Experimental, March 28, 2013

16 Cortisol Levels and Risk for Psychosis: Initial Findings from the North American Prodrome Longitudinal Study Biological Psychiatry, April 5, 2013

17 Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder Australian and New Zealand Journal of Psychiatry, March 6, 2013

18 Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only Journal of Psychiatric Research, April 15, 2013

19 Efficacy of vitamin C as an adjunct to fluoxetine therapy in pediatric major depressive disorder: a randomized, double-blind, placebo-controlled pilot study Nutrition Journal, March 14, 2013    Free full text

20 Efficiacy of Melatonin in Chronic Tension Type Headache Patients and Effects on Anxiety and Depression Journal of Neurological Sciences (Turkish), April 1, 2013    Free full text